Person · CIK 1073385

B Lynne Parshall

Director at Cytokinetics and Foghorn Therapeutics; COO at Ionis Pharmaceuticals

Earlier: Akcea Therapeutics, Regulus Therapeutics, Cardiodynamics International and Corautus Genetics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$76.1M

Noticed on Form 144$13.1M

Bought on Form 4$3M

Companies7

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Cytokinetics CYTK	Common Stock	Directly	10,784	Sep 1, 2026 · Filing · EDGAR
Cytokinetics CYTK	Non-Qualified Stock Option (Right to Buy) exercise $77.15, expires May 26, 2036, into Common Stock	Directly	4,301	May 27, 2026 · Filing · EDGAR
Foghorn Therapeutics FHTX	Stock Options (Right to buy) exercise $4.08, expires Jun 23, 2036, into Common Stock	Directly	28,000	Jun 24, 2026 · Filing · EDGAR
Ionis Pharmaceuticals ISIS	Common Stock	Directly	51,344	Apr 15, 2026 · Filing · EDGAR
Ionis Pharmaceuticals ISIS	Common Stock	Bu daughter	5,000	Sep 6, 2012 · Filing · EDGAR
Ionis Pharmaceuticals ISIS	Restricted Stock Unit into Common Stock	Directly	5,220	Jul 15, 2025 · Filing · EDGAR
Regulus Therapeutics	Common Stock	Directly	5,516,305	Nov 3, 2014 · Filing · EDGAR
Regulus Therapeutics	Common Stock	See footnote	7,049,500	Oct 10, 2012 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q3 2026	$357K	$355K	—
Q2 2026	$752K	—	—
Q1 2026	$720K	$1.4M	—
Q4 2025	$682K	$690K	—
Q3 2025	$1.2M	$1.4M	—
Q3 2024	$1.7M	$1.7M	—
Q2 2024	$506K	$506K	—
Q4 2023	$5.9M	$6.5M	—
Q3 2023	$451K	$451K	—
Q3 2022	$1.6M	Not machine-readable	—
Q4 2021	$1.6M	Not machine-readable	—
Q4 2020	$2.5M	Not machine-readable	—
Q2 2020	$413K	Not machine-readable	—
Q2 2019	$3.8M	Not machine-readable	—
Q1 2019	$1.2M	Not machine-readable	—
Q1 2018	$310K	Not machine-readable	—
Q4 2017	$1M	Not machine-readable	—
Q1 2017	$563K	Not machine-readable	—
Q4 2016	$728K	Not machine-readable	—
Q3 2016	$374K	Not machine-readable	—
Q1 2016	$265K	Not machine-readable	—
Q4 2015	$507K	Not machine-readable	—
Q3 2015	$712K	Not machine-readable	—
Q2 2015	$684K	Not machine-readable	—
Q1 2015	$974K	Not machine-readable	—
Q4 2014	$22.7M	Not machine-readable	—
Q3 2014	$1.2M	Not machine-readable	—
Q2 2014	$60K	Not machine-readable	—
Q1 2014	$4.5M	Not machine-readable	—
Q4 2013	$4.5M	Not machine-readable	—
Q3 2013	$5.2M	Not machine-readable	—
Q2 2013	$3.1M	Not machine-readable	—
Q1 2013	$11K	Not machine-readable	—
Q4 2012	—	—	$3M
Q3 2012	$1.1M	Not machine-readable	—
Q4 2011	$207K	Not machine-readable	—
Q4 2010	$246K	Not machine-readable	—
Q4 2009	$1.6M	Not machine-readable	—
Q3 2009	$14K	Not machine-readable	—
Q1 2009	$28K	Not machine-readable	—
Q4 2008	$339K	Not machine-readable	—
Q3 2008	$19K	Not machine-readable	—
Q1 2008	$46K	Not machine-readable	—
Q4 2007	$665K	Not machine-readable	—
Q3 2007	$473K	Not machine-readable	—
Q4 2006	$603K	Not machine-readable	—
Q3 2005	$41K	Not machine-readable	—
Q2 2005	$18K	Not machine-readable	—

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Aug 20, 2025 · 3 notices
Sep 1, 2026	5,000 · ~$355K	Sep 1, 2026	Sold as noticed Sold 5,000 at $71.48 on Sep 1 · $357K Form 4	Filing · EDGAR
Mar 2, 2026	10,000 · ~$622K	Mar 2, 2026	Partly sold Sold 5,000 at $61.21 on Mar 2 · $306K likely match Form 4	Filing · EDGAR
Nov 19, 2025	5,000 · ~$331K	Nov 19, 2025	Sold as noticed Sold 5,000 at $64.73 on Nov 19 · $324K Form 4	Filing · EDGAR
Ionis Pharmaceuticals ISIS · Stifel Nicolaus & Company · 10b5-1 plan adopted May 6, 2025 · 3 notices
Feb 11, 2026	10,000 · ~$827K	Feb 11, 2026	Sold as noticed Sold 10,000 in 3 sales, Feb 11 to Apr 15 · $795K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Oct 15, 2025	5,000 · ~$359K	Oct 15, 2025	Not sold within 90 days	Filing · EDGAR
Sep 2, 2025	20,000 · ~$1M	Sep 2, 2025	Sold as noticed Sold 20,000 in 2 sales, Sep 2 to Sep 2 · $1M Form 4	Filing · EDGAR
Ionis Pharmaceuticals ISIS · Stifel Nicolaus & Company · No 10b5-1 plan stated · 1 notice
Aug 6, 2025	10,000 · ~$419K	Aug 6, 2025	Sold as noticed Sold 10,000 in 3 sales, Aug 6 to Oct 15 · $568K Form 4 (1) · Form 4 (2)	Filing · EDGAR
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 4, 2024 · 8 notices
Sep 9, 2024	5,000 · ~$275K	Sep 9, 2024	Sold as noticed Sold 5,000 at $54.92 on Sep 9 · $275K Form 4	Filing · EDGAR
Aug 26, 2024	5,000 · ~$286K	Aug 26, 2024	Sold as noticed Sold 5,000 at $57.26 on Aug 26 · $286K Form 4	Filing · EDGAR
Aug 12, 2024	5,000 · ~$276K	Aug 12, 2024	Sold as noticed Sold 5,000 at $55.20 on Aug 12 · $276K Form 4	Filing · EDGAR
Jul 29, 2024	5,000 · ~$299K	Jul 29, 2024	Sold as noticed Sold 5,000 at $59.84 on Jul 29 · $299K Form 4	Filing · EDGAR
Jul 15, 2024	5,000 · ~$279K	Jul 15, 2024	Sold as noticed Sold 5,000 at $55.82 on Jul 15 · $279K Form 4	Filing · EDGAR
Jul 1, 2024	5,000 · ~$271K	Jul 1, 2024	Sold as noticed Sold 5,000 at $54.22 on Jul 1 · $271K Form 4	Filing · EDGAR
Jun 17, 2024	5,000 · ~$263K	Jun 17, 2024	Sold as noticed Sold 5,000 at $52.55 on Jun 17 · $263K Form 4	Filing · EDGAR
Jun 3, 2024	5,000 · ~$243K	Jun 3, 2024	Sold as noticed Sold 5,000 at $48.64 on Jun 3 · $243K Form 4	Filing · EDGAR
Ionis Pharmaceuticals ISIS · Insight Securities · 10b5-1 plan adopted Sep 27, 2023 · 1 notice
Dec 26, 2023	117,638 · ~$6.1M	Dec 26, 2023	Sold as noticed Sold 117,638 in 3 sales, Dec 26 to Dec 28 · $5.9M Form 4	Filing · EDGAR
Ionis Pharmaceuticals ISIS · Insight Securities · 10b5-1 plan adopted Nov 16, 2022 · 1 notice
Oct 12, 2023	10,000 · ~$451K	Sep 26, 2023	Not sold within 90 days	Filing · EDGAR
Ionis Pharmaceuticals ISIS · Insight Securities · 10b5-1 plan adopted Nov 14, 2022 · 1 notice
Sep 26, 2023	10,000 · ~$451K	Sep 26, 2023	Sold as noticed Sold 10,000 at $45.13 on Sep 26 · $451K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 243 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Cytokinetics (CYTK): Sold 5,000 at $74.08 on Jun 1, 2026 · $370K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 30,296 at $52.79 on Sep 1, 2022 · $1.6M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 2,798 at $40.00 on Nov 5, 2021 · $112K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 4,166 at $40.00 on Nov 5, 2021 · $167K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 4,032 at $40.00 on Nov 5, 2021 · $161K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 20,000 at $40.00 on Nov 5, 2021 · $800K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 8,333 at $35.73 on Oct 19, 2021 · $298K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 1,999 at $35.73 on Oct 19, 2021 · $71K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $60.00 on Dec 23, 2020 · $600K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,590 at $50.05 on Nov 25, 2020 · $180K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 710 at $50.82 on Nov 24, 2020 · $36K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,200 at $50.12 on Nov 23, 2020 · $160K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 5,936 at $30.00 on Oct 5, 2020 · $178K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 20,000 at $30.00 on Oct 5, 2020 · $600K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 4,375 at $30.00 on Oct 5, 2020 · $131K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 20,000 at $30.00 on Oct 5, 2020 · $600K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 6,510 at $25.00 on Jun 22, 2020 · $163K	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 10,000 at $25.00 on Jun 22, 2020 · $250K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 50,000 at $75.01 on Apr 29, 2019 · $3.8M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 8,334 at $75.00 on Mar 12, 2019 · $625K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 8,333 at $70.00 on Feb 27, 2019 · $583K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,986 at $51.76 on Jan 16, 2018 · $310K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 8,333 at $65.00 on Oct 18, 2017 · $542K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 7,785 at $65.00 on Oct 18, 2017 · $506K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 4,625 at $49.26 on Mar 1, 2017 · $228K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,076 at $46.29 on Jan 17, 2017 · $96K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,696 at $46.29 on Jan 17, 2017 · $125K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,509 at $46.29 on Jan 17, 2017 · $70K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 965 at $46.29 on Jan 17, 2017 · $45K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,000 at $50.00 on Dec 15, 2016 · $50K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,000 at $50.00 on Dec 15, 2016 · $50K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,000 at $50.00 on Dec 15, 2016 · $50K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,000 at $50.00 on Dec 15, 2016 · $50K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,500 at $43.17 on Dec 1, 2016 · $237K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 7,000 at $41.49 on Dec 1, 2016 · $290K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,635 at $30.05 on Sep 1, 2016 · $109K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 8,865 at $29.82 on Sep 1, 2016 · $264K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,303 at $41.46 on Jan 19, 2016 · $95K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,219 at $41.46 on Jan 19, 2016 · $51K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,003 at $41.47 on Jan 19, 2016 · $42K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 667 at $41.46 on Jan 19, 2016 · $28K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 809 at $61.05 on Jan 4, 2016 · $49K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,436 at $42.39 on Oct 2, 2015 · $146K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,000 at $40.10 on Oct 2, 2015 · $80K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,838 at $40.13 on Oct 1, 2015 · $114K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 4,162 at $40.13 on Oct 1, 2015 · $167K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 4,843 at $57.01 on Jul 6, 2015 · $276K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,375 at $57.01 on Jul 6, 2015 · $78K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 6,218 at $57.56 on Jul 1, 2015 · $358K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,565 at $63.07 on Apr 7, 2015 · $351K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,377 at $61.93 on Apr 1, 2015 · $333K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,818 at $67.96 on Jan 16, 2015 · $124K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,372 at $67.96 on Jan 16, 2015 · $93K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 903 at $67.96 on Jan 16, 2015 · $61K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 11,200 at $62.12 on Jan 2, 2015 · $696K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,279,411 at $15.94 on Nov 3, 2014 · $20.4M	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 8,561 at $45.12 on Oct 30, 2014 · $386K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,510 at $45.12 on Oct 30, 2014 · $113K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,850 at $15.19 on Oct 24, 2014 · $28K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,700 at $14.24 on Oct 23, 2014 · $24K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 109,534 at $14.00 on Oct 22, 2014 · $1.5M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,000 at $6.79 on Oct 17, 2014 · $20K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 4,800 at $6.76 on Oct 16, 2014 · $32K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 4,300 at $6.67 on Oct 15, 2014 · $29K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,000 at $6.41 on Oct 10, 2014 · $13K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 4,750 at $6.58 on Oct 9, 2014 · $31K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,300 at $6.63 on Oct 8, 2014 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,300 at $6.88 on Oct 3, 2014 · $23K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,750 at $6.64 on Oct 2, 2014 · $25K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,250 at $6.71 on Oct 1, 2014 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,500 at $7.04 on Sep 26, 2014 · $18K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,500 at $7.12 on Sep 25, 2014 · $18K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,750 at $7.19 on Sep 24, 2014 · $27K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 4,100 at $7.22 on Sep 19, 2014 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,500 at $7.40 on Sep 18, 2014 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,100 at $7.43 on Sep 17, 2014 · $16K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,500 at $7.96 on Sep 12, 2014 · $28K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,400 at $7.83 on Sep 11, 2014 · $27K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,000 at $7.70 on Sep 10, 2014 · $15K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,400 at $7.07 on Sep 5, 2014 · $17K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 6,000 at $7.11 on Sep 4, 2014 · $43K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,650 at $6.95 on Sep 3, 2014 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 443 at $40.24 on Sep 2, 2014 · $18K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,628 at $40.24 on Sep 2, 2014 · $428K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,500 at $6.84 on Aug 29, 2014 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,000 at $6.96 on Aug 28, 2014 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,500 at $7.21 on Aug 27, 2014 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 5,250 at $6.75 on Aug 22, 2014 · $35K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,500 at $6.89 on Aug 21, 2014 · $17K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,000 at $7.14 on Aug 20, 2014 · $21K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,450 at $6.98 on Aug 15, 2014 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,750 at $7.04 on Aug 14, 2014 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,250 at $7.02 on Aug 13, 2014 · $16K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,850 at $6.80 on Aug 8, 2014 · $13K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,600 at $6.66 on Aug 7, 2014 · $17K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,150 at $7.08 on Aug 6, 2014 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,600 at $6.21 on Aug 1, 2014 · $16K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,750 at $6.42 on Jul 31, 2014 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,000 at $6.60 on Jul 30, 2014 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,700 at $6.55 on Jul 25, 2014 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,850 at $6.81 on Jul 24, 2014 · $13K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,700 at $6.88 on Jul 23, 2014 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 5,000 at $6.80 on Jul 18, 2014 · $34K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 5,000 at $6.58 on Jul 17, 2014 · $33K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,500 at $6.59 on Jul 16, 2014 · $23K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,750 at $6.48 on Jul 11, 2014 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 4,500 at $6.69 on Jul 10, 2014 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,800 at $7.08 on Jul 9, 2014 · $13K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,200 at $8.07 on Jul 3, 2014 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,100 at $8.07 on Jul 2, 2014 · $25K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 3,150 at $7.91 on Jun 27, 2014 · $25K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 1,700 at $7.89 on Jun 26, 2014 · $13K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regulus Therapeutics: Sold 2,750 at $7.84 on Jun 25, 2014 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 15,875 at $50.36 on Jan 30, 2014 · $800K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 23,635 at $50.36 on Jan 30, 2014 · $1.2M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $48.81 on Jan 29, 2014 · $244K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $48.81 on Jan 29, 2014 · $244K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $48.81 on Jan 29, 2014 · $244K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 31,028 at $48.81 on Jan 29, 2014 · $1.5M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,972 at $48.81 on Jan 29, 2014 · $194K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 988 at $47.08 on Jan 16, 2014 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 653 at $47.08 on Jan 16, 2014 · $31K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 37,811 at $40.91 on Dec 26, 2013 · $1.5M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 20,000 at $41.00 on Dec 24, 2013 · $820K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,771 at $41.68 on Dec 23, 2013 · $74K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 48,229 at $41.68 on Dec 23, 2013 · $2M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $35.90 on Sep 20, 2013 · $359K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 30,000 at $35.90 on Sep 20, 2013 · $1.1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 30,000 at $35.02 on Sep 19, 2013 · $1.1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 20,000 at $35.12 on Sep 19, 2013 · $702K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,985 at $31.18 on Sep 11, 2013 · $62K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,520 at $31.18 on Sep 11, 2013 · $47K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 30,000 at $31.65 on Sep 10, 2013 · $949K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 30,000 at $30.42 on Sep 9, 2013 · $912K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 18,400 at $22.50 on Apr 25, 2013 · $414K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 7,454 at $22.50 on Apr 25, 2013 · $168K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 30,000 at $22.12 on Apr 24, 2013 · $664K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $22.10 on Apr 23, 2013 · $221K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $22.10 on Apr 23, 2013 · $221K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $22.10 on Apr 23, 2013 · $221K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 30,000 at $20.99 on Apr 22, 2013 · $630K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 30,000 at $20.01 on Apr 19, 2013 · $600K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 759 at $14.00 on Jan 16, 2013 · $11K	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $15.12 on Sep 7, 2012 · $76K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $15.12 on Sep 7, 2012 · $76K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,506 at $15.12 on Sep 7, 2012 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $15.00 on Sep 6, 2012 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $15.04 on Sep 6, 2012 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $15.00 on Sep 6, 2012 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $15.04 on Sep 6, 2012 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $15.00 on Sep 6, 2012 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,506 at $15.04 on Sep 6, 2012 · $38K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,494 at $15.04 on Sep 6, 2012 · $37K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,000 at $15.00 on Sep 5, 2012 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $15.00 on Sep 4, 2012 · $150K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $15.00 on Sep 4, 2012 · $150K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $15.00 on Sep 4, 2012 · $150K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,200 at $6.92 on Dec 21, 2011 · $15K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,200 at $6.92 on Dec 21, 2011 · $15K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,363 at $6.92 on Dec 21, 2011 · $16K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,800 at $6.82 on Dec 20, 2011 · $19K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 700 at $6.92 on Dec 20, 2011 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,800 at $6.82 on Dec 20, 2011 · $19K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 700 at $6.92 on Dec 20, 2011 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 700 at $6.92 on Dec 20, 2011 · $5K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,900 at $6.82 on Dec 20, 2011 · $20K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,054 at $6.82 on Dec 19, 2011 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 246 at $6.90 on Dec 19, 2011 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 246 at $6.90 on Dec 19, 2011 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,054 at $6.82 on Dec 19, 2011 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 246 at $6.90 on Dec 19, 2011 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,054 at $6.82 on Dec 19, 2011 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,000 at $6.79 on Dec 16, 2011 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,000 at $6.79 on Dec 16, 2011 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,000 at $6.79 on Dec 16, 2011 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 6,400 at $10.32 on Dec 29, 2010 · $66K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,800 at $10.42 on Dec 27, 2010 · $113K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 800 at $10.53 on Dec 23, 2010 · $8K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 650 at $10.53 on Dec 23, 2010 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 650 at $10.53 on Dec 23, 2010 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 4,350 at $10.52 on Dec 22, 2010 · $46K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,545 at $11.21 on Dec 31, 2009 · $40K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,545 at $11.21 on Dec 31, 2009 · $40K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,000 at $11.07 on Dec 30, 2009 · $33K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 3,000 at $11.07 on Dec 30, 2009 · $33K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,000 at $11.17 on Dec 28, 2009 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,000 at $11.17 on Dec 28, 2009 · $11K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 7,500 at $10.59 on Dec 23, 2009 · $79K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 7,500 at $10.59 on Dec 23, 2009 · $79K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,910 at $10.59 on Dec 23, 2009 · $20K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $10.13 on Dec 22, 2009 · $101K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $10.03 on Dec 15, 2009 · $100K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $9.98 on Dec 11, 2009 · $100K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 13,000 at $10.15 on Dec 10, 2009 · $132K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $10.26 on Dec 9, 2009 · $103K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 20,000 at $10.53 on Dec 8, 2009 · $211K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 25,000 at $10.52 on Dec 7, 2009 · $263K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 20,000 at $10.55 on Dec 4, 2009 · $211K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 876 at $15.71 on Jul 6, 2009 · $14K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,949 at $14.20 on Jan 5, 2009 · $28K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $13.37 on Dec 30, 2008 · $67K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $13.25 on Dec 26, 2008 · $66K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 7,000 at $13.52 on Dec 23, 2008 · $95K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 8,000 at $13.93 on Dec 19, 2008 · $111K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 1,338 at $13.91 on Jul 3, 2008 · $19K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,406 at $19.28 on Jan 8, 2008 · $46K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 20,000 at $18.01 on Nov 28, 2007 · $360K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 20,000 at $15.23 on Oct 1, 2007 · $305K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $15.03 on Sep 28, 2007 · $75K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 20,000 at $15.27 on Sep 27, 2007 · $305K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 6,466 at $13.03 on Sep 11, 2007 · $84K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 835 at $9.85 on Jul 3, 2007 · $8K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $13.36 on Nov 13, 2006 · $134K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $13.36 on Nov 13, 2006 · $134K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $13.36 on Nov 13, 2006 · $134K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 10,000 at $10.13 on Nov 9, 2006 · $101K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $10.13 on Nov 9, 2006 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 5,000 at $10.13 on Nov 9, 2006 · $51K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 500 at $5.25 on Sep 19, 2005 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 150 at $5.30 on Sep 19, 2005 · $795 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 53 at $5.34 on Sep 19, 2005 · $283 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 100 at $5.35 on Sep 19, 2005 · $535 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 347 at $5.36 on Sep 19, 2005 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 300 at $5.31 on Sep 16, 2005 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 208 at $5.15 on Sep 15, 2005 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 200 at $5.25 on Sep 15, 2005 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 200 at $5.30 on Sep 15, 2005 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 450 at $5.29 on Sep 14, 2005 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 500 at $5.40 on Sep 13, 2005 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 200 at $5.49 on Sep 12, 2005 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 300 at $5.54 on Sep 12, 2005 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 200 at $5.50 on Sep 12, 2005 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 200 at $5.54 on Sep 9, 2005 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 400 at $5.50 on Sep 9, 2005 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 400 at $5.45 on Sep 9, 2005 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 100 at $5.45 on Sep 8, 2005 · $545 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 100 at $5.49 on Sep 8, 2005 · $549 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 100 at $5.30 on Sep 8, 2005 · $530 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 100 at $5.40 on Sep 8, 2005 · $540 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 600 at $5.35 on Sep 8, 2005 · $3K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,702 at $3.85 on Jul 5, 2005 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,000 at $4.00 on Jun 24, 2005 · $8K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Ionis Pharmaceuticals (ISIS): Sold 2,446 at $4.01 on Jun 24, 2005 · $10K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Cytokinetics CYTK Director · filings 2013 to 2026 · sold $8.7M · $3.5M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Sep 1, 2026	Sale under a 10b5-1 plan	−5,000	$71.48	$357K	10,784 direct	Filing · EDGAR
Jun 1, 2026	Sale under a 10b5-1 plan	−5,000	$74.08	$370K	15,784 direct	Filing · EDGAR
May 27, 2026	Grant or award from the company	+2,851			20,784 direct	Filing · EDGAR
May 27, 2026	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+4,301			4,301 direct	Filing · EDGAR
Mar 2, 2026	Sale under a 10b5-1 plan	−5,000	$61.21	$306K	17,933 direct	Filing · EDGAR
Nov 19, 2025	Sale under a 10b5-1 plan	−5,000	$64.73	$324K	22,933 direct	Filing · EDGAR
May 14, 2025	Grant or award from the company	+7,333			27,933 direct	Filing · EDGAR
May 14, 2025	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+10,880			10,880 direct	Filing · EDGAR
Sep 9, 2024	Option or RSU exercised or converted	+5,000	$21.61	$108K	25,600 direct	Filing · EDGAR
Sep 9, 2024	Sale under a 10b5-1 plan	−5,000	$54.92	$275K	20,600 direct	Filing · EDGAR
Sep 9, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			0 direct	Filing · EDGAR
Aug 26, 2024	Option or RSU exercised or converted	+5,000	$21.61	$108K	25,600 direct	Filing · EDGAR
Aug 26, 2024	Sale under a 10b5-1 plan	−5,000	$57.26	$286K	20,600 direct	Filing · EDGAR
Aug 26, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			5,000 direct	Filing · EDGAR
Aug 12, 2024	Option or RSU exercised or converted	+5,000	$21.61	$108K	25,600 direct	Filing · EDGAR
Aug 12, 2024	Sale under a 10b5-1 plan	−5,000	$55.20	$276K	20,600 direct	Filing · EDGAR
Aug 12, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			10,000 direct	Filing · EDGAR
Jul 29, 2024	Option or RSU exercised or converted	+5,000	$21.61	$108K	25,600 direct	Filing · EDGAR
Jul 29, 2024	Sale under a 10b5-1 plan	−5,000	$59.84	$299K	20,600 direct	Filing · EDGAR
Jul 29, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			15,000 direct	Filing · EDGAR
Jul 15, 2024	Option or RSU exercised or converted	+5,000	$10.68	$53K	25,600 direct	Filing · EDGAR
Jul 15, 2024	Sale under a 10b5-1 plan	−5,000	$55.82	$279K	20,600 direct	Filing · EDGAR
Jul 15, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			0 direct	Filing · EDGAR
Jul 1, 2024	Option or RSU exercised or converted	+5,000	$10.68	$53K	25,600 direct	Filing · EDGAR
Jul 1, 2024	Sale under a 10b5-1 plan	−5,000	$54.22	$271K	20,600 direct	Filing · EDGAR
Jul 1, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			5,000 direct	Filing · EDGAR
Jun 17, 2024	Option or RSU exercised or converted	+5,000	$10.68	$53K	25,600 direct	Filing · EDGAR
Jun 17, 2024	Sale under a 10b5-1 plan	−5,000	$52.55	$263K	20,600 direct	Filing · EDGAR
Jun 17, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			10,000 direct	Filing · EDGAR
Jun 3, 2024	Option or RSU exercised or converted	+5,000	$10.68	$53K	20,600 direct	Filing · EDGAR
Jun 3, 2024	Sale under a 10b5-1 plan	−5,000	$48.64	$243K	15,600 direct	Filing · EDGAR
Jun 3, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,000			15,000 direct	Filing · EDGAR
May 15, 2024	Grant or award from the company	+5,600			20,600 direct	Filing · EDGAR
May 15, 2024	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+3,636			3,636 direct	Filing · EDGAR
May 10, 2023	Grant or award from the company	+5,000			15,000 direct	Filing · EDGAR
May 10, 2023	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted	+5,714	$8.75	$50K	15,714 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted	+20,000	$9.45	$189K	35,714 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted	+4,582	$6.82	$31K	40,296 direct	Filing · EDGAR
Sep 1, 2022	Sale under a 10b5-1 plan	−30,296	$52.79	$1.6M	10,000 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,714			0 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−20,000			0 direct	Filing · EDGAR
Sep 1, 2022	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−4,582			0 direct	Filing · EDGAR
May 10, 2022	Grant or award from the company	+5,000			10,000 direct	Filing · EDGAR
May 10, 2022	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000			10,000 direct	Filing · EDGAR
Nov 5, 2021	Option or RSU exercised or converted	+20,000	$14.25	$285K	25,000 direct	Filing · EDGAR
Nov 5, 2021	Sale under a 10b5-1 plan	−20,000	$40.00	$800K	5,000 direct	Filing · EDGAR
Nov 5, 2021	Option or RSU exercised or converted	+4,032	$12.40	$50K	9,032 direct	Filing · EDGAR
Nov 5, 2021	Sale under a 10b5-1 plan	−4,032	$40.00	$161K	5,000 direct	Filing · EDGAR
Nov 5, 2021	Option or RSU exercised or converted	+4,166	$6.78	$28K	9,166 direct	Filing · EDGAR
Nov 5, 2021	Sale under a 10b5-1 plan	−4,166	$40.00	$167K	5,000 direct	Filing · EDGAR
Nov 5, 2021	Option or RSU exercised or converted	+2,798	$6.84	$19K	7,798 direct	Filing · EDGAR
Nov 5, 2021	Sale under a 10b5-1 plan	−2,798	$40.00	$112K	5,000 direct	Filing · EDGAR
Nov 5, 2021	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−4,166			0 direct	Filing · EDGAR
Nov 5, 2021	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−2,798			0 direct	Filing · EDGAR
Nov 5, 2021	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−4,032			0 direct	Filing · EDGAR
Nov 5, 2021	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−20,000			0 direct	Filing · EDGAR
Oct 19, 2021	Option or RSU exercised or converted	+1,999	$6.84	$14K	6,999 direct	Filing · EDGAR
Oct 19, 2021	Sale under a 10b5-1 plan	−1,999	$35.73	$71K	5,000 direct	Filing · EDGAR
Oct 19, 2021	Option or RSU exercised or converted	+8,333	$6.60	$55K	13,333 direct	Filing · EDGAR

40 earlier transactions are in the filing list below.

Foghorn Therapeutics FHTX Director · filings 2022 to 2026

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 24, 2026	Grant or award from the company Stock Options (Right to buy)	+28,000	$4.08	$114K	28,000 direct	Filing · EDGAR
Jun 17, 2025	Grant or award from the company Stock Option (right to buy)	+25,000	$4.79	$120K	25,000 direct	Filing · EDGAR
Jun 26, 2024	Grant or award from the company Stock Options (Right to buy)	+16,000	$5.52	$88K	16,000 direct	Filing · EDGAR
Jun 21, 2023	Grant or award from the company Stock Option (right to buy)	+16,000			16,000 direct	Filing · EDGAR
Aug 16, 2022	Grant or award from the company Stock Options (Right to buy)	+32,000	$16.34	$523K	32,000 direct	Filing · EDGAR

Ionis Pharmaceuticals ISIS COO · filings 2003 to 2026 · sold $44.5M · $9.6M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 15, 2026	Sale under a 10b5-1 plan	−4,466	$76.19	$340K	51,878 direct	Filing · EDGAR
Apr 15, 2026	Sale under a 10b5-1 plan	−534	$76.97	$41K	51,344 direct	Filing · EDGAR
Feb 11, 2026	Sale under a 10b5-1 plan	−5,000	$82.72	$414K	56,344 direct	Filing · EDGAR
Oct 15, 2025	Sale under a 10b5-1 plan	−5,000	$71.74	$359K	61,344 direct	Filing · EDGAR
Sep 2, 2025	Sale under a 10b5-1 plan	−10,750	$50.42	$542K	75,594 direct	Filing · EDGAR
Sep 2, 2025	Sale under a 10b5-1 plan	−9,250	$51.49	$476K	66,344 direct	Filing · EDGAR
Aug 6, 2025	Sale under a 10b5-1 plan	−4,600	$41.87	$193K	86,744 direct	Filing · EDGAR
Aug 6, 2025	Sale under a 10b5-1 plan	−400	$42.63	$17K	86,344 direct	Filing · EDGAR
Jul 15, 2025	Option or RSU exercised or converted	+4,079			91,344 direct	Filing · EDGAR
Jul 15, 2025	Option or RSU exercised or converted Restricted Stock Unit	−4,079			5,220 direct	Filing · EDGAR
Jul 1, 2025	Grant or award from the company Non-Qualified Stock Option (right to buy)	+11,518			11,518 direct	Filing · EDGAR
Jul 1, 2025	Grant or award from the company Restricted Stock Unit	+5,220			9,299 direct	Filing · EDGAR
Jul 15, 2024	Option or RSU exercised or converted	+4,677			87,265 direct	Filing · EDGAR
Jul 15, 2024	Option or RSU exercised or converted Restricted Stock Unit	−4,677			4,079 direct	Filing · EDGAR
Jul 1, 2024	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,111			10,111 direct	Filing · EDGAR
Jul 1, 2024	Grant or award from the company Restricted Stock Unit	+4,079			8,756 direct	Filing · EDGAR
Dec 28, 2023	Option or RSU exercised or converted	+42,525	$47.34	$2M	125,113 direct	Filing · EDGAR
Dec 28, 2023	Sale under a 10b5-1 plan	−42,525	$50.19	$2.1M	82,588 direct	Filing · EDGAR
Dec 28, 2023	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−42,525			0 direct	Filing · EDGAR
Dec 27, 2023	Option or RSU exercised or converted	+50,000	$47.34	$2.4M	132,588 direct	Filing · EDGAR
Dec 27, 2023	Sale under a 10b5-1 plan	−50,000	$50.23	$2.5M	82,588 direct	Filing · EDGAR
Dec 27, 2023	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−50,000			42,525 direct	Filing · EDGAR
Dec 26, 2023	Option or RSU exercised or converted	+25,113	$47.34	$1.2M	107,701 direct	Filing · EDGAR
Dec 26, 2023	Sale under a 10b5-1 plan	−25,113	$51.46	$1.3M	82,588 direct	Filing · EDGAR
Dec 26, 2023	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−25,113			92,525 direct	Filing · EDGAR
Sep 26, 2023	Sale under a 10b5-1 plan	−10,000	$45.13	$451K	82,588 direct	Filing · EDGAR
Jul 17, 2023	Option or RSU exercised or converted	+1,777			87,255 direct	Filing · EDGAR
Jul 17, 2023	Option or RSU exercised or converted	+5,333			92,588 direct	Filing · EDGAR
Jul 17, 2023	Option or RSU exercised or converted Restricted Stock Unit	−1,777			10,010 direct	Filing · EDGAR
Jul 17, 2023	Option or RSU exercised or converted Restricted Stock Unit	−5,333			4,677 direct	Filing · EDGAR
Jul 3, 2023	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,321			10,321 direct	Filing · EDGAR
Jul 3, 2023	Grant or award from the company Restricted Stock Unit	+4,677			11,787 direct	Filing · EDGAR
Jul 15, 2022	Option or RSU exercised or converted	+5,333			82,813 direct	Filing · EDGAR
Jul 15, 2022	Option or RSU exercised or converted	+2,665			85,478 direct	Filing · EDGAR
Jul 15, 2022	Option or RSU exercised or converted Restricted Stock Unit	−5,333			9,775 direct	Filing · EDGAR
Jul 15, 2022	Option or RSU exercised or converted Restricted Stock Unit	−2,665			7,110 direct	Filing · EDGAR
Jul 1, 2022	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Jul 1, 2022	Grant or award from the company Restricted Stock Unit	+5,333			15,108 direct	Filing · EDGAR
Jan 18, 2022	Option or RSU exercised or converted	+5,754			79,132 direct	Filing · EDGAR
Jan 18, 2022	Shares withheld for tax or exercise price	−1,652	$30.12	$50K	77,480 direct	Filing · EDGAR
Jan 18, 2022	Option or RSU exercised or converted Restricted Stock Unit	−5,754			9,775 direct	Filing · EDGAR
Jul 15, 2021	Option or RSU exercised or converted	+5,333			70,711 direct	Filing · EDGAR
Jul 15, 2021	Option or RSU exercised or converted	+889			71,600 direct	Filing · EDGAR
Jul 15, 2021	Option or RSU exercised or converted	+1,778			73,378 direct	Filing · EDGAR
Jul 15, 2021	Option or RSU exercised or converted Restricted Stock Unit	−5,333			18,196 direct	Filing · EDGAR
Jul 15, 2021	Option or RSU exercised or converted Restricted Stock Unit	−889			17,307 direct	Filing · EDGAR
Jul 15, 2021	Option or RSU exercised or converted Restricted Stock Unit	−1,778			15,529 direct	Filing · EDGAR
Jul 1, 2021	Grant or award from the company Non-Qualified Stock Option (right to buy)	+12,000			12,000 direct	Filing · EDGAR
Jul 1, 2021	Grant or award from the company Restricted Stock Unit	+5,333			23,529 direct	Filing · EDGAR
Jan 15, 2021	Option or RSU exercised or converted	+10,655			68,119 direct	Filing · EDGAR
Jan 15, 2021	Shares withheld for tax or exercise price	−2,741	$61.28	$168K	65,378 direct	Filing · EDGAR
Jan 15, 2021	Option or RSU exercised or converted Restricted Stock Units	−10,655			5,754 direct	Filing · EDGAR
Dec 23, 2020	Sale under a 10b5-1 plan	−10,000	$60.00	$600K	57,464 direct	Filing · EDGAR
Nov 25, 2020	Option or RSU exercised or converted	+3,590	$39.87	$143K	71,054 direct	Filing · EDGAR
Nov 25, 2020	Sale under a 10b5-1 plan	−3,590	$50.05	$180K	67,464 direct	Filing · EDGAR
Nov 25, 2020	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−3,590			0 direct	Filing · EDGAR
Nov 24, 2020	Option or RSU exercised or converted	+710	$39.87	$28K	68,174 direct	Filing · EDGAR
Nov 24, 2020	Sale under a 10b5-1 plan	−710	$50.82	$36K	67,464 direct	Filing · EDGAR
Nov 24, 2020	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−710			3,590 direct	Filing · EDGAR
Nov 23, 2020	Option or RSU exercised or converted	+3,200	$39.87	$128K	70,664 direct	Filing · EDGAR

541 earlier transactions are in the filing list below.

Akcea Therapeutics Director · filings 2017 to 2020

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 12, 2020	Returned to the company Stock Option (right to buy)	−26,400	$2.01	$53K	0 direct	Filing · EDGAR
Apr 13, 2020	Grant or award from the company Stock Option (right to buy)	+26,400			26,400 direct	Filing · EDGAR
Jun 14, 2019	Grant or award from the company Stock Option (right to buy)	+26,400			26,400 direct	Filing · EDGAR
Jun 1, 2018	Grant or award from the company Stock Option (right to buy)	+26,400			26,400 direct	Filing · EDGAR
May 7, 2018	Grant or award from the company Stock Option (right to buy)	+53,000			53,000 direct	Filing · EDGAR

Regulus Therapeutics Director · filings 2012 to 2014 · sold $23M · bought $3M

Date	Transaction	Shares	Price	Value	Held after	Source
Nov 3, 2014	Open-market or private sale	−1,279,411	$15.94	$20.4M	5,516,305 direct	Filing · EDGAR
Oct 24, 2014	Sale under a 10b5-1 plan	−1,850	$15.19	$28K	6,795,716 direct	Filing · EDGAR
Oct 23, 2014	Sale under a 10b5-1 plan	−1,700	$14.24	$24K	6,797,566 direct	Filing · EDGAR
Oct 22, 2014	Sale under a 10b5-1 plan	−109,534	$14.00	$1.5M	6,799,266 direct	Filing · EDGAR
Oct 17, 2014	Sale under a 10b5-1 plan	−3,000	$6.79	$20K	6,908,800 direct	Filing · EDGAR
Oct 16, 2014	Sale under a 10b5-1 plan	−4,800	$6.76	$32K	6,911,800 direct	Filing · EDGAR
Oct 15, 2014	Sale under a 10b5-1 plan	−4,300	$6.67	$29K	6,916,600 direct	Filing · EDGAR
Oct 10, 2014	Sale under a 10b5-1 plan	−2,000	$6.41	$13K	6,920,900 direct	Filing · EDGAR
Oct 9, 2014	Sale under a 10b5-1 plan	−4,750	$6.58	$31K	6,922,900 direct	Filing · EDGAR
Oct 8, 2014	Sale under a 10b5-1 plan	−3,300	$6.63	$22K	6,927,650 direct	Filing · EDGAR
Oct 3, 2014	Sale under a 10b5-1 plan	−3,300	$6.88	$23K	6,930,950 direct	Filing · EDGAR
Oct 2, 2014	Sale under a 10b5-1 plan	−3,750	$6.64	$25K	6,934,250 direct	Filing · EDGAR
Oct 1, 2014	Sale under a 10b5-1 plan	−3,250	$6.71	$22K	6,938,000 direct	Filing · EDGAR
Sep 26, 2014	Sale under a 10b5-1 plan	−2,500	$7.04	$18K	6,941,250 direct	Filing · EDGAR
Sep 25, 2014	Sale under a 10b5-1 plan	−2,500	$7.12	$18K	6,943,750 direct	Filing · EDGAR
Sep 24, 2014	Sale under a 10b5-1 plan	−3,750	$7.19	$27K	6,946,250 direct	Filing · EDGAR
Sep 19, 2014	Sale under a 10b5-1 plan	−4,100	$7.22	$30K	6,950,000 direct	Filing · EDGAR
Sep 18, 2014	Sale under a 10b5-1 plan	−1,500	$7.40	$11K	6,954,100 direct	Filing · EDGAR
Sep 17, 2014	Sale under a 10b5-1 plan	−2,100	$7.43	$16K	6,955,600 direct	Filing · EDGAR
Sep 12, 2014	Sale under a 10b5-1 plan	−3,500	$7.96	$28K	6,957,700 direct	Filing · EDGAR
Sep 11, 2014	Sale under a 10b5-1 plan	−3,400	$7.83	$27K	6,961,200 direct	Filing · EDGAR
Sep 10, 2014	Sale under a 10b5-1 plan	−2,000	$7.70	$15K	6,964,600 direct	Filing · EDGAR
Sep 5, 2014	Sale under a 10b5-1 plan	−2,400	$7.07	$17K	6,966,600 direct	Filing · EDGAR
Sep 4, 2014	Sale under a 10b5-1 plan	−6,000	$7.11	$43K	6,969,000 direct	Filing · EDGAR
Sep 3, 2014	Sale under a 10b5-1 plan	−1,650	$6.95	$11K	6,975,000 direct	Filing · EDGAR
Aug 29, 2014	Sale under a 10b5-1 plan	−1,500	$6.84	$10K	6,976,650 direct	Filing · EDGAR
Aug 28, 2014	Sale under a 10b5-1 plan	−2,000	$6.96	$14K	6,978,150 direct	Filing · EDGAR
Aug 27, 2014	Sale under a 10b5-1 plan	−1,500	$7.21	$11K	6,980,150 direct	Filing · EDGAR
Aug 22, 2014	Sale under a 10b5-1 plan	−5,250	$6.75	$35K	6,981,650 direct	Filing · EDGAR
Aug 21, 2014	Sale under a 10b5-1 plan	−2,500	$6.89	$17K	6,986,900 direct	Filing · EDGAR
Aug 20, 2014	Sale under a 10b5-1 plan	−3,000	$7.14	$21K	6,989,400 direct	Filing · EDGAR
Aug 15, 2014	Sale under a 10b5-1 plan	−1,450	$6.98	$10K	6,992,400 direct	Filing · EDGAR
Aug 14, 2014	Sale under a 10b5-1 plan	−1,750	$7.04	$12K	6,993,850 direct	Filing · EDGAR
Aug 13, 2014	Sale under a 10b5-1 plan	−2,250	$7.02	$16K	6,995,600 direct	Filing · EDGAR
Aug 8, 2014	Sale under a 10b5-1 plan	−1,850	$6.80	$13K	6,997,850 direct	Filing · EDGAR
Aug 7, 2014	Sale under a 10b5-1 plan	−2,600	$6.66	$17K	6,999,700 direct	Filing · EDGAR
Aug 6, 2014	Sale under a 10b5-1 plan	−3,150	$7.08	$22K	7,002,300 direct	Filing · EDGAR
Aug 1, 2014	Sale under a 10b5-1 plan	−2,600	$6.21	$16K	7,005,450 direct	Filing · EDGAR
Jul 31, 2014	Sale under a 10b5-1 plan	−1,750	$6.42	$11K	7,008,050 direct	Filing · EDGAR
Jul 30, 2014	Sale under a 10b5-1 plan	−1,000	$6.60	$7K	7,009,800 direct	Filing · EDGAR
Jul 25, 2014	Sale under a 10b5-1 plan	−1,700	$6.55	$11K	7,010,800 direct	Filing · EDGAR
Jul 24, 2014	Sale under a 10b5-1 plan	−1,850	$6.81	$13K	7,012,500 direct	Filing · EDGAR
Jul 23, 2014	Sale under a 10b5-1 plan	−1,700	$6.88	$12K	7,014,350 direct	Filing · EDGAR
Jul 18, 2014	Sale under a 10b5-1 plan	−5,000	$6.80	$34K	7,016,050 direct	Filing · EDGAR
Jul 17, 2014	Sale under a 10b5-1 plan	−5,000	$6.58	$33K	7,021,050 direct	Filing · EDGAR
Jul 16, 2014	Sale under a 10b5-1 plan	−3,500	$6.59	$23K	7,026,050 direct	Filing · EDGAR
Jul 11, 2014	Sale under a 10b5-1 plan	−1,750	$6.48	$11K	7,029,550 direct	Filing · EDGAR
Jul 10, 2014	Sale under a 10b5-1 plan	−4,500	$6.69	$30K	7,031,300 direct	Filing · EDGAR
Jul 9, 2014	Sale under a 10b5-1 plan	−1,800	$7.08	$13K	7,035,800 direct	Filing · EDGAR
Jul 3, 2014	Sale under a 10b5-1 plan	−1,200	$8.07	$10K	7,037,600 direct	Filing · EDGAR
Jul 2, 2014	Sale under a 10b5-1 plan	−3,100	$8.07	$25K	7,038,800 direct	Filing · EDGAR
Jun 27, 2014	Sale under a 10b5-1 plan	−3,150	$7.91	$25K	7,041,900 direct	Filing · EDGAR
Jun 26, 2014	Sale under a 10b5-1 plan	−1,700	$7.89	$13K	7,045,050 direct	Filing · EDGAR
Jun 25, 2014	Sale under a 10b5-1 plan	−2,750	$7.84	$22K	7,046,750 direct	Filing · EDGAR
Oct 10, 2012	Derivative converted	+6,299,500			6,299,500 See footnote	Filing · EDGAR
Oct 10, 2012	Open-market or private purchase	+750,000	$4.00	$3M	7,049,500 See footnote	Filing · EDGAR
Oct 10, 2012	Derivative converted Series A Preferred Stock	−6,299,500			0 See footnote	Filing · EDGAR

Cardiodynamics International Director · filings 2005 to 2009

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 14, 2009	Returned to the company	−21,000	$1.35	$28K	0 direct	Filing · EDGAR
Aug 14, 2009	Returned to the company Stock Option (Right to Buy)	−1,714			0 direct	Filing · EDGAR
Aug 14, 2009	Returned to the company Stock Option (Right to Buy)	−3,428			0 direct	Filing · EDGAR
Aug 14, 2009	Returned to the company Stock Option (Right to Buy)	−2,571			0 direct	Filing · EDGAR
Aug 14, 2009	Returned to the company Stock Option (Right to Buy)	−2,571			0 direct	Filing · EDGAR
Jul 1, 2008	Grant or award from the company	+15,000			21,000 direct	Filing · EDGAR
Aug 28, 2007	Grant or award from the company	+30,000			42,000 direct	Filing · EDGAR
Aug 28, 2007	Grant or award from the company Stock Options (Right to Buy)	+18,000			18,000 direct	Filing · EDGAR
Jan 24, 2007	Grant or award from the company	+12,000			12,000 direct	Filing · EDGAR
Jul 20, 2006	Grant or award from the company Stock Options (Right to Buy)	+18,000			18,000 direct	Filing · EDGAR
Nov 28, 2005	Grant or award from the company Stock Option (Right to buy)	+24,000			24,000 direct	Filing · EDGAR
Aug 1, 2005	Grant or award from the company Stock Options (Right to buy)	+12,000			12,000 direct	Filing · EDGAR

Corautus Genetics Director · filings 2005 to 2006

Date	Transaction	Shares	Held after	Source
May 11, 2006	Grant or award from the company Stock option (right to buy)	+114,554	114,554 direct	Filing · EDGAR
May 12, 2005	Grant or award from the company Stock Option (right to buy)	+24,000	24,000 direct	Filing · EDGAR
May 12, 2005	Grant or award from the company Stock Option (right to buy)	+18,000	18,000 direct	Filing · EDGAR

All 235 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 1, 2026	Form 144	Cytokinetics CYTK	Filing · EDGAR
Sep 1, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 25, 2026	Form 4	Foghorn Therapeutics FHTX	Filing · EDGAR
Jun 1, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 27, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 17, 2026	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Mar 2, 2026	Form 144	Cytokinetics CYTK	Filing · EDGAR
Mar 2, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 13, 2026	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Feb 11, 2026	Form 144	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 19, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Nov 19, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 16, 2025	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 15, 2025	Form 144	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 4, 2025	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 2, 2025	Form 144	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Aug 8, 2025	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Aug 6, 2025	Form 144	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 17, 2025	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 2, 2025	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jun 17, 2025	Form 4	Foghorn Therapeutics FHTX	Filing · EDGAR
May 15, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Sep 9, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Sep 9, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Aug 26, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Aug 26, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Aug 12, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Aug 12, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 31, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 29, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Jul 17, 2024	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 16, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 15, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Jul 3, 2024	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 1, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Jul 1, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 28, 2024	Form 4	Foghorn Therapeutics FHTX	Filing · EDGAR
Jun 17, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
Jun 17, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 4, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 3, 2024	Form 144	Cytokinetics CYTK	Filing · EDGAR
May 16, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 28, 2023	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 27, 2023	Form 144	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 12, 2023	Form 144/A	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 28, 2023	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 26, 2023	Form 144	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 19, 2023	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 6, 2023	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jun 22, 2023	Form 4	Foghorn Therapeutics FHTX	Filing · EDGAR
May 18, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Sep 9, 2022	Form 3/A	Foghorn Therapeutics FHTX	Filing · EDGAR
Sep 1, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Aug 18, 2022	Form 4	Foghorn Therapeutics FHTX	Filing · EDGAR
Aug 18, 2022	Form 3	Foghorn Therapeutics FHTX	Filing · EDGAR
Jul 19, 2022	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 6, 2022	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 11, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 20, 2022	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 5, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 20, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 19, 2021	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 6, 2021	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 13, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 20, 2021	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 28, 2020	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 30, 2020	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 25, 2020	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 13, 2020	Form 4	Akcea Therapeutics	Filing · EDGAR
Oct 6, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 6, 2020	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jun 23, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 14, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 15, 2020	Form 4	Akcea Therapeutics	Filing · EDGAR
Feb 14, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 17, 2020	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 3, 2019	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jun 18, 2019	Form 4	Akcea Therapeutics	Filing · EDGAR
May 17, 2019	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 1, 2019	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Mar 14, 2019	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Mar 1, 2019	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 17, 2019	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 4, 2019	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 3, 2018	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jun 5, 2018	Form 4	Akcea Therapeutics	Filing · EDGAR
May 17, 2018	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 8, 2018	Form 4	Akcea Therapeutics	Filing · EDGAR
Jan 17, 2018	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 4, 2018	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 2, 2018	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 20, 2017	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 13, 2017	Form 3	Akcea Therapeutics	Filing · EDGAR
Jul 3, 2017	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 22, 2017	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 2, 2017	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 18, 2017	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 4, 2017	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2017	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 16, 2016	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 2, 2016	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 6, 2016	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 1, 2016	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 20, 2016	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 19, 2016	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 6, 2016	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2016	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 9, 2015	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 5, 2015	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 8, 2015	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 2, 2015	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 21, 2015	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 8, 2015	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Apr 6, 2015	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 20, 2015	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 5, 2015	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 5, 2015	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 5, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Oct 31, 2014	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 24, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Oct 17, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Oct 10, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Oct 3, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Sep 26, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Sep 19, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Sep 12, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Sep 5, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Sep 4, 2014	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Aug 29, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Aug 22, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Aug 15, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Aug 8, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Aug 1, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Jul 25, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Jul 18, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Jul 11, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Jul 7, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
Jul 1, 2014	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jun 27, 2014	Form 4	Regulus Therapeutics	Filing · EDGAR
May 22, 2014	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 31, 2014	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 24, 2014	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 17, 2014	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 3, 2014	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 3, 2014	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 30, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 24, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 23, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 11, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 29, 2013	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 26, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Apr 23, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Apr 8, 2013	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 8, 2013	Form 4	Cytokinetics CYTK	Filing · EDGAR
Feb 8, 2013	Form 3	Cytokinetics CYTK	Filing · EDGAR
Feb 1, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 17, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 11, 2013	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 11, 2012	Form 4	Regulus Therapeutics	Filing · EDGAR
Oct 4, 2012	Form 3	Regulus Therapeutics	Filing · EDGAR
Sep 11, 2012	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 6, 2012	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 17, 2012	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 13, 2012	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 3, 2012	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 22, 2011	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 20, 2011	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 24, 2011	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 3, 2011	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 29, 2010	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 27, 2010	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Feb 1, 2010	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 5, 2010	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 31, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 30, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 23, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 17, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 14, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 10, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 8, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Aug 14, 2009	Form 4	Cardiodynamics International	Filing · EDGAR
Jul 8, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 6, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 2, 2009	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 29, 2008	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Dec 22, 2008	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 18, 2008	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 3, 2008	Form 4	Cardiodynamics International	Filing · EDGAR
Jul 3, 2008	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 10, 2008	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 4, 2008	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 30, 2007	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 1, 2007	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 12, 2007	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Aug 29, 2007	Form 4	Cardiodynamics International	Filing · EDGAR
Jul 3, 2007	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Apr 18, 2007	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 26, 2007	Form 4	Cardiodynamics International	Filing · EDGAR
Jan 4, 2007	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 13, 2006	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 25, 2006	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 21, 2006	Form 4	Cardiodynamics International	Filing · EDGAR
Jul 5, 2006	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 15, 2006	Form 4	Corautus Genetics	Filing · EDGAR
Jan 4, 2006	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Nov 29, 2005	Form 4/A	Cardiodynamics International	Filing · EDGAR
Nov 29, 2005	Form 4	Cardiodynamics International	Filing · EDGAR
Sep 19, 2005	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 15, 2005	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Sep 12, 2005	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Aug 2, 2005	Form 3/A	Cardiodynamics International	Filing · EDGAR
Aug 2, 2005	Form 4	Cardiodynamics International	Filing · EDGAR
Aug 1, 2005	Form 3	Cardiodynamics International	Filing · EDGAR
Jul 6, 2005	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jun 28, 2005	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 16, 2005	Form 4	Corautus Genetics	Filing · EDGAR
May 16, 2005	Form 3	Corautus Genetics	Filing · EDGAR
Jan 4, 2005	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Oct 1, 2004	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jul 2, 2004	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 30, 2004	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Jan 5, 2004	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
May 13, 2003	Form 4	Ionis Pharmaceuticals ISIS	Filing · EDGAR
Feb 21, 2003	Form 4	Paper or text filing, not machine-readable	EDGAR
Jan 31, 2003	Form 4/A	Paper or text filing, not machine-readable	EDGAR
Jan 3, 2003	Form 4	Paper or text filing, not machine-readable	EDGAR
Oct 18, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Oct 16, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Oct 15, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Oct 15, 2002	Form 4/A	Paper or text filing, not machine-readable	EDGAR
Oct 15, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Oct 4, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Oct 2, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Sep 30, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Sep 30, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 10:34 AM ET. The filing on SEC.gov is the record.